Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
2010 1
2014 1
2015 1
2018 1
2019 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Adrenal Gland Pheochromocytoma"
Page 1
Metastatic pheochromocytoma and paraganglioma.
Angelousi A, Kassi E, Zografos G, Kaltsas G. Angelousi A, et al. Eur J Clin Invest. 2015 Sep;45(9):986-97. doi: 10.1111/eci.12495. Eur J Clin Invest. 2015. PMID: 26183460 Review.
BACKGROUND: Metastatic pheochromocytomas (PCs) and paragangliomas (PGLs) are rare neuroendocrine tumours with a strong genetic background. ...Treatment with (131)I-MIBG or radiolabelled somatostatin analogues is considered for unresectable disease. Conventional chem …
BACKGROUND: Metastatic pheochromocytomas (PCs) and paragangliomas (PGLs) are rare neuroendocrine tumours with a strong genetic backgr …
Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.
Ferreira CV, Siqueira DR, Romitti M, Ceolin L, Brasil BA, Meurer L, Capp C, Maia AL. Ferreira CV, et al. Int J Mol Sci. 2014 Mar 26;15(4):5323-36. doi: 10.3390/ijms15045323. Int J Mol Sci. 2014. PMID: 24675699 Free PMC article.
Pheochromocytoma (PHEO), a rare catecholamine producing tumor arising from the chromaffin cells, may occurs sporadically (76%-80%) or as part of inherited syndromes (20%-24%). ...VEGF-A, VEGFR-1 and VEGFR-2 staining were detected in nearly all PHEO samples. No significant …
Pheochromocytoma (PHEO), a rare catecholamine producing tumor arising from the chromaffin cells, may occurs sporadically (76%-80%) or …
SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
Donato S, Simões H, Pinto AT, M Cavaco B, Leite V. Donato S, et al. Endocrine. 2019 Aug;65(2):408-415. doi: 10.1007/s12020-019-01953-6. Epub 2019 May 18. Endocrine. 2019. PMID: 31104306
PURPOSE: Germline mutations in the four genes that encode the succinate dehydrogenase complex (SDHx) are a risk factor for developing pheochromocytomas and/or paragangliomas. The precise genotype-phenotype correlations are still uncertain and the most common SDHx genetic d …
PURPOSE: Germline mutations in the four genes that encode the succinate dehydrogenase complex (SDHx) are a risk factor for developing phe …
Prognostic value of [(18)F]FDG-PET prior to [(131)I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL).
Takenaka J, Watanabe S, Abe T, Hirata K, Uchiyama Y, Kimura R, Shinohara N, Kudo K. Takenaka J, et al. Ann Nucl Med. 2023 Jan;37(1):10-17. doi: 10.1007/s12149-022-01798-6. Epub 2022 Oct 27. Ann Nucl Med. 2023. PMID: 36301465
OBJECTIVE: Pheochromocytomas and paragangliomas (PPGLs) are rare tumors arising from the neural crest cells that form the sympathetic and parasympathetic nervous systems. Radiotherapy with [(131)I]metaiodobenzylguanidine (MIBG) is recommended for unresectable PPGLs. …
OBJECTIVE: Pheochromocytomas and paragangliomas (PPGLs) are rare tumors arising from the neural crest cells that form the sympathetic …
Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients with Metastatic Pheochromocytomas/Paragangliomas.
Zhou Y, Cui Y, Zhang D, Tong A. Zhou Y, et al. J Clin Endocrinol Metab. 2023 Feb 15;108(3):755-766. doi: 10.1210/clinem/dgac657. J Clin Endocrinol Metab. 2023. PMID: 36383456
CONTEXT: Tyrosine kinase inhibitors (TKIs) can be used to treat locally unresectable or distantly metastatic pheochromocytomas/paragangliomas (PPGLs), such as sunitinib, according to the National Comprehensive Cancer Network guidelines in 2022. ...The MIONRS scale a …
CONTEXT: Tyrosine kinase inhibitors (TKIs) can be used to treat locally unresectable or distantly metastatic pheochromocytomas …
Surgical management of abdominal manifestations of type 1 neurofibromatosis: experience of a single center.
Cavallaro G, Basile U, Polistena A, Giustini S, Arena R, Scorsi A, Zinnamosca L, Letizia C, Calvieri S, De Toma G. Cavallaro G, et al. Am Surg. 2010 Apr;76(4):389-96. Am Surg. 2010. PMID: 20420249
In the group of patients with a diagnosis of von Recklinghausen disease, 10 patients underwent surgical treatment for gastrointestinal and retroperitoneal tumors associated with NF1. Three patients underwent adrenalectomy for pheochromocytoma (in one case associated with j …
In the group of patients with a diagnosis of von Recklinghausen disease, 10 patients underwent surgical treatment for gastrointestinal and r …
Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.
Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C. Pryma DA, et al. J Nucl Med. 2019 May;60(5):623-630. doi: 10.2967/jnumed.118.217463. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291194 Free PMC article. Clinical Trial.
Patients with metastatic or unresectable (advanced) pheochromocytoma and paraganglioma (PPGL) have poor prognoses and few treatment options. ...Decreases in elevated (1.5 times the upper limit of normal at baseline) serum chromogranin levels were observed, wi …
Patients with metastatic or unresectable (advanced) pheochromocytoma and paraganglioma (PPGL) have poor prognoses and few trea …
High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991.
Proye C, Vix M, Goropoulos A, Kerlo P, Lecomte-Houcke M. Proye C, et al. J Endocrinol Invest. 1992 Oct;15(9):651-63. doi: 10.1007/BF03345810. J Endocrinol Invest. 1992. PMID: 1479148
In this surgical series of 100 pheochromocytomas (PH), where 91 cases were studied and followed up, the frequency of malignancy appears high (29%) on macroscopic criteria observed at the first operation (25 out 26 cases of malignant PH) or thanks to the occurrence o …
In this surgical series of 100 pheochromocytomas (PH), where 91 cases were studied and followed up, the frequency of malignancy appea …
Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
Shapiro B, Sisson JC, Wieland DM, Mangner TJ, Zempel SM, Mudgett E, Gross MD, Carey JE, Zasadny KR, Beierwaltes WH. Shapiro B, et al. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):269-76. J Nucl Biol Med (1991). 1991. PMID: 1823834
Twenty-eight patients with histologically proven metastatic or invasive, unresectable pheochromocytomas, which were shown to concentrate and retain tracer doses of [131I]metaiodobenzylguanidine (131I-MIBG), were treated with therapeutic quantities of this radiopharm …
Twenty-eight patients with histologically proven metastatic or invasive, unresectable pheochromocytomas, which were shown to c …